Nuveen Asset Management, LLC Exelixis, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 3,721,058 shares of EXEL stock, worth $134 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

3,721,058

Previous 4,051,537 8.16%

Holding current value

$134 Million

Previous $91 Million 6.07%

% of portfolio

0.03%

Previous 0.03%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$21.96 - $27.6 $7.26 Million - $9.12 Million	-330,479 Reduced 8.16%	3,721,058 $96.6 Million
Q2 2024 Aug 09, 2024	BUY	$20.34 - $23.73 $923,883 - $1.08 Million	45,422 Added 1.13%	4,051,537 $91 Million
Q1 2024 May 13, 2024	BUY	$20.17 - $23.93 $10.6 Million - $12.6 Million	527,256 Added 15.16%	4,006,115 $95.1 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $7.23 Million - $9.06 Million	-375,404 Reduced 9.74%	3,478,859 $83.5 Million
Q3 2023 Nov 14, 2023	BUY	$19.04 - $22.74 $6.55 Million - $7.83 Million	344,220 Added 9.81%	3,854,263 $84.2 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $9.49 Million - $10.7 Million	522,132 Added 17.47%	3,510,043 $67.1 Million
Q1 2023 May 15, 2023	BUY	$16.3 - $19.41 $29 Million - $34.5 Million	1,777,191 Added 146.79%	2,987,911 $58 Million
Q4 2022 Feb 14, 2023	BUY	$14.96 - $17.39 $5.62 Million - $6.54 Million	375,837 Added 45.02%	1,210,720 $19.4 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $4.91 Million - $6.98 Million	-313,356 Reduced 27.29%	834,883 $13.1 Million
Q2 2022 Aug 15, 2022	BUY	$17.44 - $23.16 $3.9 Million - $5.18 Million	223,609 Added 24.18%	1,148,239 $23.9 Million
Q1 2022 May 16, 2022	SELL	$17.03 - $22.67 $1.33 Million - $1.76 Million	-77,829 Reduced 7.76%	924,630 $19.6 Million
Q4 2021 Feb 14, 2022	SELL	$15.84 - $21.88 $2.76 Million - $3.81 Million	-173,985 Reduced 14.79%	1,002,459 $18.3 Million
Q3 2021 Nov 12, 2021	SELL	$16.3 - $21.14 $3.67 Million - $4.77 Million	-225,460 Reduced 16.08%	1,176,444 $24.9 Million
Q2 2021 Aug 16, 2021	BUY	$17.95 - $25.56 $1.92 Million - $2.74 Million	107,066 Added 8.27%	1,401,904 $25.5 Million
Q1 2021 May 17, 2021	SELL	$20.53 - $25.22 $1.41 Million - $1.74 Million	-68,831 Reduced 5.05%	1,294,838 $29.3 Million
Q4 2020 May 17, 2021	BUY	$18.39 - $24.8 $612,736 - $826,311	33,319 Added 2.5%	1,363,669 $27.4 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $1.25 Million - $1.69 Million	67,993 Added 5.39%	1,330,350 $26.7 Million
Q3 2020 Nov 16, 2020	SELL	$20.67 - $26.94 $3.93 Million - $5.12 Million	-190,089 Reduced 13.09%	1,262,357 $30.9 Million
Q2 2020 Aug 14, 2020	BUY	$16.46 - $27.42 $2.95 Million - $4.92 Million	179,256 Added 14.08%	1,452,446 $34.5 Million
Q1 2020 May 14, 2020	SELL	$14.46 - $21.8 $22.8 Million - $34.4 Million	-1,580,217 Reduced 55.38%	1,273,190 $21.9 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $4.42 Million - $5.51 Million	-291,516 Reduced 9.27%	2,853,407 $50.3 Million
Q3 2019 Nov 14, 2019	BUY	$17.68 - $22.65 $16.5 Million - $21.1 Million	931,113 Added 42.06%	3,144,923 $55.6 Million
Q2 2019 Aug 15, 2019	BUY	$18.93 - $24.75 $41.9 Million - $54.8 Million	2,213,810 New	2,213,810 $47.3 Million
Q1 2018 May 14, 2018	SELL	$22.15 - $31.89 $7.66 Million - $11 Million	-345,758 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $8.38 Million - $10.7 Million	345,758	345,758 $0

Others Institutions Holding EXEL

# of Institutions

503

Shares Held

244M

Call Options Held

2.54M

Put Options Held

2.29M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.6B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Exelixis, Inc. Transaction History